Skip to main content
. 2015 Jan 31;37(2):115–119. doi: 10.1016/j.bjhh.2015.01.006

Table 5.

Comparison of lupus patients with (n = 80) and without (n = 370) lymphopenia.

With lymphopenia
n (%)
Without lymphopenia
n (%)
p-Value OR 95% CI
Age (years; median, IQR) 35.0 (27.0–44.5) 41.0 (29.5–49.0) 0.004
Age at diagnosis (years; median, IQR) 30.0 (22.0–33.0) 26.0 (19.0–35.7) 0.01
Glomerulonephritis – n (%) 45/80 (56.2) 136/369 (36.8) 0.001 2.2 1.35–3.59
Thrombocytopenia – n (%) 23/79 (29.1) 71/370 (19.1) 0.04 1.7 0.99–2.99
Leukopenia – n (%) 34/80 (42.5) 99/369 (26.9) 0.005 2.0 1.21–3.31
Anti-La – n (%) 20/76 (26.3) 59/355 (16.6) 0.04 2.0 1.50–4.32
Anti-RNP – n (%) 31/73 (42.4) 77/243 (22.4) 0.0004 2.5 1.21–3.31
Anti-SM – n (%) 25/75 (33.3) 60/351 (17.0) 0.0014 3.0 1.42–6.50
Lupus anticoagulant – n (%) 15/71 (21.1) 43/330 (13.0) 0.07
Antiphospholipid syndrome – n (%) 12/75 (16.0) 21/357 (5.8) 0.002 2.2 1.35–3.59

IQR: interquartile range; OR: odds ratio; 95% CI: 95% confidence interval.